Dr Reddy's Laboratories Ltd
NYSE:RDY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Dr Reddy's Laboratories Ltd
NYSE:RDY
|
IN |
|
B
|
Brunello Cucinelli SpA
F:8BU
|
IT |
|
P
|
Pacific Industrial Co Ltd
TSE:7250
|
JP |
|
Z
|
Zalando SE
XHAM:ZAL
|
DE |
|
Bradespar SA
BOVESPA:BRAP4
|
BR |
|
InDex Pharmaceuticals Holding AB
F:1NP
|
SE |
|
U
|
UMH Properties Inc
F:WXE
|
US |
|
Capita PLC
LSE:CPI
|
UK |
|
Elecnor SA
LSE:0K97
|
ES |
|
M
|
Modulight Oyj
OMXH:MODU
|
FI |
|
Allianz SE
XETRA:ALV
|
DE |
|
Li Ning Co Ltd
OTC:LNNGF
|
CN |
|
Neste Oyj
OMXH:NESTE
|
FI |
|
L
|
LKQ Corp
LSE:0JSJ
|
US |
|
Casta Diva Group SpA
F:99C
|
IT |
|
A
|
Aptargroup Inc
F:AGT
|
US |
|
S
|
Securitas AB
DUS:S7MB
|
SE |
|
Brunello Cucinelli SpA
F:8BU0
|
IT |
|
Saab AB
OTC:SAABF
|
SE |
|
U
|
UMB Financial Corp
F:UMB
|
US |
|
Nikon Corp
F:NKN
|
JP |
|
H
|
Hong Kong and China Gas Co Ltd
XHAM:HCG
|
HK |
|
Capita PLC
F:CTA0
|
UK |
|
H
|
Haier Smart Home Co Ltd
DUS:690D
|
CN |
Wall St Price Targets
RDY Price Targets Summary
Dr Reddy's Laboratories Ltd
According to Wall Street analysts, the average 1-year price target for
RDY is 14.8 USD with a low forecast of 11.35 USD and a high forecast of 19.85 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RDY's stock price target?
Price Target
14.8
USD
According to Wall Street analysts, the average 1-year price target for
RDY is 14.8 USD with a low forecast of 11.35 USD and a high forecast of 19.85 USD.
What is the Revenue forecast for Dr Reddy's Laboratories Ltd?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 4 years is 8%.
What is the Gross Profit forecast for Dr Reddy's Laboratories Ltd?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 4 years is 6%.
What is the Operating Income forecast for Dr Reddy's Laboratories Ltd?
Projected CAGR
18%
Over the last 13 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 4 years is 18%.
What is the Pre-Tax Income forecast for Dr Reddy's Laboratories Ltd?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 7%. The projected CAGR for the next 2 years is 17%.
What is the Net Income forecast for Dr Reddy's Laboratories Ltd?
Projected CAGR
16%
Over the last 13 years, the compound annual growth rate for Net Income has been 8%. The projected CAGR for the next 4 years is 16%.